John Sullivan-Bolyai Selected Research

FV-100

1/2017

FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Sullivan-Bolyai Research Topics

Disease

1	Rabies (Hydrophobia) 01/2022
1	Neuralgia (Stump Neuralgia) 01/2017
1	Pain (Aches) 01/2017
1	Herpes Zoster 01/2017

Drug/Important Bio-Agent (IBA)

1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Valacyclovir (Valtrex)FDA LinkGeneric 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2017
1	FV-100IBA 01/2017